Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 15;22(1):2.
doi: 10.1186/s12868-020-00606-z.

Post-status epilepticus treatment with the Fyn inhibitor, saracatinib, improves cognitive function in mice

Affiliations

Post-status epilepticus treatment with the Fyn inhibitor, saracatinib, improves cognitive function in mice

Xin-Ming Luo et al. BMC Neurosci. .

Abstract

Background: Status epilepticus (SE) is a life-threatening neurological disorder. The hippocampus, as an important area of the brain that regulates cognitive function, is usually damaged after SE, and cognitive deficits often result from hippocampal neurons lost after SE. Fyn, a non-receptor Src family of tyrosine kinases, is potentially associated with the onset of seizure. Saracatinib, a Fyn inhibitor, suppresses epileptogenesis and reduces epileptiform spikes. However, whether saracatinib inhibits cognitive deficits after SE is still unknown.

Methods: In the present study, a pilocarpine-induced SE mouse model was used to answer this question by using the Morris water maze and normal object recognition behavioral tests.

Results: We found that saracatinib inhibited the loss in cognitive function following SE. Furthermore, we found that the number of hippocampal neurons in the saracatinib treatment group was increased, when compared to the SE group.

Conclusions: These results showed that saracatinib can improve cognitive functions by reducing the loss of hippocampal neurons after SE, suggesting that Fyn dysfunction is involved in cognitive deficits after SE, and that the inhibition of Fyn is a possible treatment to improve cognitive function in SE patients.

Keywords: Cognitive function; Fyn inhibitor; Hippocampal neurons; Saracatinib; Status epilepticus.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Time depiction of the experimental scheme
Fig. 2
Fig. 2
Saracatinib treatment reduces the frequency of epileptic spikes after status epilepticus (SE). a Representative electroencephalogram traces from the hippocampus 14 days after SE. b Quantitative analysis of interictal spikes. c Quantitative analysis of duration of spontaneous seizure. d Quantitative analysis of frequency of spontaneous seizure. Data are expressed as the mean ± SEM (n = 5/group). **p < 0.01
Fig. 3
Fig. 3
Saracatinib improves the cognitive function after status epilepticus. Cognitive function was analyzed using the Morris water maze. a Latency to the target platform during a five-day training period. b Distance swum to the target platform during a five-day training period. c Swimming velocity on days 3–5 during the training period. d The number of crossings of the platform site during the probe test. e Time spent in the quadrant of the platform placed in previous locations during the probe test. f, g The cognitive functions were analyzed using the normal object recognition test. f Preference index. (G) Recognition index. Data are expressed as the mean ± SEM (n = 8 or 9/group). *p < 0.05, **p < 0.01. * CON vs SE; # SE vs Sar + SE
Fig. 4
Fig. 4
Saracatinib rescues the loss of hippocampal neurons after status epilepticus. a Immunohistochemical detection of NeuN+ neurons in the dental gyrus of the hippocampus. b Quantification of NeuN+ neurons in each group. Scale bar = 100 µm in lower magnification; = 25 µm in higher magnification insert. Data are expressed as the mean ± SEM (n = 5/group). *p < 0.05, **p < 0.01

Similar articles

Cited by

References

    1. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol. 1995;12(4):316–325. doi: 10.1097/00004691-199512040-00003. - DOI - PubMed
    1. Fountain NB. Status epilepticus: risk factors and complications. Epilepsia. 2000;41(Suppl 2):S23–S30. doi: 10.1111/j.1528-1157.2000.tb01521.x. - DOI - PubMed
    1. Sidhu MK, Stretton J, Winston GP, McEvoy AW, Symms M, Thompson PJ, Koepp MJ, Duncan JS. Memory network plasticity after temporal lobe resection: a longitudinal functional imaging study. Brain. 2016;139(Pt 2):415–430. doi: 10.1093/brain/awv365. - DOI - PMC - PubMed
    1. Zhu X, Yao Y, Yang J, Ge Q, Niu D, Liu X, Zhang C, Gan G, Zhang A, Yao H. Seizure-induced neuroinflammation contributes to ectopic neurogenesis and aggressive behavior in pilocarpine-induced status epilepticus mice. Neuropharmacology. 2020;170:108044. doi: 10.1016/j.neuropharm.2020.108044. - DOI - PubMed
    1. Lu YF, Kojima N, Tomizawa K, Moriwaki A, Matsushita M, Obata K, Matsui H. Enhanced synaptic transmission and reduced threshold for LTP induction in fyn-transgenic mice. Eur J Neurosci. 1999;11(1):75–82. doi: 10.1046/j.1460-9568.1999.00407.x. - DOI - PubMed

Publication types

LinkOut - more resources